Management of transmodiolar and transmacular cochleovestibular schwannomas with and without cochlear implantation.
Management transmodiolärer und transmakulärer Vestibularis- und Cochlearisschwannome mit und ohne Cochleaimplantation.
Ear, inner
Evoked potentials, auditory, brain stem
Neuroma, acoustic
Rehabilitation
Schwannoma, intralabyrinthine
Journal
HNO
ISSN: 1433-0458
Titre abrégé: HNO
Pays: Germany
ID NLM: 2985099R
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
pubmed:
13
10
2020
medline:
9
2
2021
entrez:
12
10
2020
Statut:
ppublish
Résumé
Hearing rehabilitation with cochlear implants has attracted increasing interest also for patients with cochleovestibular schwannoma. The authors report their experience with the surgical management of tumors with rare transmodiolar or transmacular extension and outcomes after cochlear implantation (CI). This retrospective case series included nine patients with either primary intralabyrinthine tumors or secondary invasion of the inner ear from the internal auditory canal. The primary endpoint with CI, performed in six patients, was word recognition score at 65 dB SPL (sound pressure level). Secondary endpoints were intra- and postoperative electrophysiological parameters, impedance measures, the presence of a wave V in the electrically evoked (via the CI) auditory brainstem responses, the specifics of postoperative CI programming, and adverse events. Hearing rehabilitation with CI in cases of transmodiolar tumor growth could be achieved only with incomplete tumor removal, whereas tumors with transmacular growth could be completely removed. All six patients with CI had good word recognition scores for numbers in quiet conditions (80-100% at 65 dB SPL, not later than 6 to 12 months post CI activation). Four of these six patients achieved good to very good results for monosyllabic words within 1-36 months (65-85% at 65 dB SPL). The two other patients, however, had low scores for monosyllables at 6 months (25 and 15% at 65 dB SPL, respectively) with worsening of results thereafter. Cochleovestibular schwannomas with transmodiolar and transmacular extension represent a rare entity with specific management requirements. Hearing rehabilitation with CI is a principal option in these patients.
Identifiants
pubmed: 33044580
doi: 10.1007/s00106-020-00919-9
pii: 10.1007/s00106-020-00919-9
pmc: PMC7862215
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7-19Références
Otol Neurotol. 2004 Mar;25(2):160-7
pubmed: 15021777
Eur Arch Otorhinolaryngol. 2016 Sep;273(9):2373-83
pubmed: 26498948
HNO. 2019 Jun;67(Suppl 2):62-68
pubmed: 30944946
Audiol Neurootol. 2016;21(5):286-295
pubmed: 27816972
HNO. 2017 Aug;65(Suppl 2):81-86
pubmed: 28116456
Clin Otolaryngol. 2017 Feb;42(1):92-97
pubmed: 27158933
Biomed Res Int. 2018 Nov 8;2018:9163285
pubmed: 30533442
Cochlear Implants Int. 2020 Jan;21(1):9-17
pubmed: 31496442
Int Tinnitus J. 2017 Jun 01;21(1):2-6
pubmed: 28723594
Otol Neurotol. 2016 Jul;37(6):647-53
pubmed: 27273407
Laryngoscope. 2012 Jun;122(6):1361-5
pubmed: 22539093
Otol Neurotol. 2012 Oct;33(8):1339-46
pubmed: 22935813
Eur Arch Otorhinolaryngol. 2014 Aug;271(8):2119-26
pubmed: 24096818
HNO. 2011 May;59(5):437-46
pubmed: 21505923
Otol Neurotol. 2017 Jan;38(1):54-59
pubmed: 27755458
J Radiosurg SBRT. 2017;5(1):63-71
pubmed: 29296464
Otol Neurotol. 2018 Mar;39(3):365-371
pubmed: 29283914
J Neurooncol. 2019 Nov;145(2):329-337
pubmed: 31552587
J Laryngol Otol. 2013 Jun;127(6):568-73
pubmed: 23657004
Eur Arch Otorhinolaryngol. 2020 May;277(5):1297-1304
pubmed: 32008075
Acta Otolaryngol. 2005 Aug;125(8):830-9
pubmed: 16158529
Eur Arch Otorhinolaryngol. 2021 Feb;278(2):353-362
pubmed: 32504199
HNO. 2017 May;65(5):419-433
pubmed: 28421258
Otol Neurotol. 2020 Aug;41(7):e891
pubmed: 32658406
Otol Neurotol. 2019 Apr;40(4):e461-e466
pubmed: 30870381
Clin Otolaryngol. 2017 Dec;42(6):1329-1337
pubmed: 28371358
Otol Neurotol. 2005 Jan;26(1):93-7
pubmed: 15699726
Laryngoscope. 2019 Feb;129(2):482-489
pubmed: 30412276
Laryngoscope. 2013 Aug;123(8):1957-66
pubmed: 23335152
J Neurol Surg B Skull Base. 2018 Aug;79(4):319-324
pubmed: 30009110
Otol Neurotol. 2017 Dec;38(10):e401-e404
pubmed: 28938274
Laryngoscope. 2016 Aug;126(8):1877-82
pubmed: 27426941
Otol Neurotol. 2019 Dec;40(10):e966-e974
pubmed: 31524762
Otol Neurotol. 2020 Jun;41(5):e556-e562
pubmed: 31985706
J Radiosurg SBRT. 2016;4(1):69-74
pubmed: 29296428
Clin Epidemiol. 2019 Nov 08;11:981-986
pubmed: 31807080
Otol Neurotol. 2020 Dec;41(10):e1297-e1303
pubmed: 33492805
J Neurosurg. 2014 Jun;120(6):1278-87
pubmed: 24724851
Neurosurg Rev. 2021 Feb;44(1):223-238
pubmed: 32030543
Otol Neurotol. 2013 Dec;34(9):1681-7
pubmed: 24232066
HNO. 2017 Jan;65(Suppl 1):35-40
pubmed: 26886493
J Neurol Surg B Skull Base. 2019 Apr;80(2):187-195
pubmed: 30931227
Otol Neurotol. 2020 Mar;41(3):334-338
pubmed: 31923084
Otol Neurotol. 2016 Oct;37(9):e332-40
pubmed: 27631656
Otol Neurotol. 2019 Jan;40(1):e20-e24
pubmed: 30531638
AJNR Am J Neuroradiol. 2012 Jan;33(1):104-9
pubmed: 22158921
Z Med Phys. 2018 Feb;28(1):73-77
pubmed: 29054678
J Neurol Surg B Skull Base. 2019 Apr;80(2):196-202
pubmed: 30931228
HNO. 2017 Jan;65(Suppl 1):46-51
pubmed: 27590489
HNO. 2017 Sep;65(9):758-765
pubmed: 28819872
Eur Arch Otorhinolaryngol. 2020 Feb;277(2):333-342
pubmed: 31802225
J Neurosurg. 2017 May 19;:1-7
pubmed: 28524795
Otol Neurotol. 2020 Jun;41(5):694-703
pubmed: 31985710
J Neurol Surg B Skull Base. 2019 Dec;80(6):632-639
pubmed: 31750050
Otol Neurotol. 2014 Oct;35(9):1641-9
pubmed: 25098591